Cite
Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer
MLA
Barbara Kreppel, et al. “Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer.” Theranostics, vol. 7, no. 18, Sept. 2017, pp. 4359–69. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8787262f6371e52834c42b3d0235c9d9&authtype=sso&custid=ns315887.
APA
Barbara Kreppel, Florian C. Gärtner, Ambreen Khawar, Markus Essler, Elisabeth Eppard, Klaus Kopka, Ana de la Fuente, Frank Rösch, Martina Benešová, & Ralph A. Bundschuh. (2017). Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer. Theranostics, 7(18), 4359–4369.
Chicago
Barbara Kreppel, Florian C. Gärtner, Ambreen Khawar, Markus Essler, Elisabeth Eppard, Klaus Kopka, Ana de la Fuente, Frank Rösch, Martina Benešová, and Ralph A. Bundschuh. 2017. “Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer.” Theranostics 7 (18): 4359–69. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8787262f6371e52834c42b3d0235c9d9&authtype=sso&custid=ns315887.